BioAge Labs (BIOA) Free Cash Flow (2023 - 2026)
BioAge Labs (BIOA) reported Free Cash Flow of -$24.1 million for Q1 2026, down 35.32% on a YoY basis from -$37.2 million in Q1 2025, and up 15.13% sequentially from -$28.4 million in Q4 2025.
BioAge Labs (BIOA) Free Cash Flow (2023 - 2026) Analysis & Trends
BioAge Labs (BIOA) has 4 years of Free Cash Flow data on file, last reported at -$24.1 million in Q1 2026.
- For the quarter ending Q1 2026, Free Cash Flow fell 35.32% year-over-year to -$24.1 million; the trailing twelve-month figure through Mar 2026 stood at -$88.6 million (down 64.5% YoY), and the FY2025 full-year result was -$82.3 million, down 59.09% from the prior year.
- Free Cash Flow climbed to -$24.1 million in Q1 2026, from -$28.4 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of -$5.0 million in Q4 2024 to a low of -$28.4 million in Q4 2025.
- A 4-year average of -$16.7 million and a median of -$15.9 million in 2024 frame the typical range for Free Cash Flow.
- Across the five-year window, Free Cash Flow jumped 40.75% in 2024 and slumped 462.98% in 2025, its largest moves.
- Tracing BIOA's Free Cash Flow over 4 years: stood at -$8.5 million in 2023, then jumped by 40.75% to -$5.0 million in 2024, then tumbled by 462.98% to -$28.4 million in 2025, then increased by 15.13% to -$24.1 million in 2026.
- Business Quant data shows BIOA's Free Cash Flow at -$24.1 million in Q1 2026, -$28.4 million in Q4 2025, and -$16.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -208.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 291.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -373.37 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 363.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 348.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 144.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -38.00 Mn |
| 10 | BioAge Labs | 930.32 Mn | 930.32 Mn | -10.37 Mn | -24.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -24.07 Mn |
| Mar 31, 2026 | -24.07 Mn |
| Dec 31, 2025 | -28.36 Mn |
| Dec 31, 2025 | -28.36 Mn |
| Sep 30, 2025 | -16.07 Mn |
| Sep 30, 2025 | -16.07 Mn |
| Jun 30, 2025 | -20.13 Mn |
| Jun 30, 2025 | -20.13 Mn |
| Mar 31, 2025 | -17.79 Mn |
| Mar 31, 2025 | -17.79 Mn |
| Dec 31, 2024 | -5.04 Mn |
| Dec 31, 2024 | -5.04 Mn |
| Sep 30, 2024 | -15.24 Mn |
| Sep 30, 2024 | -15.24 Mn |
| Jun 30, 2024 | -15.82 Mn |
| Jun 30, 2024 | -15.82 Mn |
| Mar 31, 2024 | -15.67 Mn |
| Mar 31, 2024 | -15.67 Mn |
| Dec 31, 2023 | -8.50 Mn |
| Dec 31, 2023 | -8.50 Mn |